bioquell limited
bioquell limited Company Information
Company Number
00206372
Website
www.bioquell.comRegistered Address
c/o hill dickinson, no.1 st. paul's square, liverpool, england, L3 9SJ
Industry
Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
Telephone
01264835835
Next Accounts Due
289 days late
Group Structure
View All
Shareholders
ecolab limited 100%
bioquell limited Estimated Valuation
Pomanda estimates the enterprise value of BIOQUELL LIMITED at £0 based on a Turnover of £0 and 1.21x industry multiple (adjusted for size and gross margin).
bioquell limited Estimated Valuation
Pomanda estimates the enterprise value of BIOQUELL LIMITED at £0 based on an EBITDA of £0 and a 4.58x industry multiple (adjusted for size and gross margin).
bioquell limited Estimated Valuation
Pomanda estimates the enterprise value of BIOQUELL LIMITED at £34.8m based on Net Assets of £20.4m and 1.71x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Bioquell Limited Overview
Bioquell Limited is a live company located in liverpool, L3 9SJ with a Companies House number of 00206372. It operates in the activities of other holding companies n.e.c. sector, SIC Code 64209. Founded in June 1925, it's largest shareholder is ecolab limited with a 100% stake. Bioquell Limited is a mature, unknown sized company, Pomanda has estimated its turnover at £0 with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Bioquell Limited Health Check
Pomanda's financial health check has awarded Bioquell Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 2 areas for improvement. Company Health Check FAQs
2 Strong
0 Regular
2 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Bioquell Limited
- - Industry AVG
Growth
3 year (CAGR) sales growth of -100%, show it is growing at a slower rate (2.2%)
- - Bioquell Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Bioquell Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Bioquell Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (100)
- Bioquell Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Bioquell Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Bioquell Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Bioquell Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Bioquell Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Bioquell Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 13017 weeks, this is more cash available to meet short term requirements (18 weeks)
- - Bioquell Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 0.3%, this is a lower level of debt than the average (71.2%)
- - Bioquell Limited
- - Industry AVG
BIOQUELL LIMITED financials
Bioquell Limited's latest turnover from November 2021 is 0 and the company has net assets of £20.4 million. According to their latest financial statements, we estimate that Bioquell Limited has 1 employee and maintains cash reserves of £13.3 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Nov 2021 | Nov 2020 | Nov 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 0 | 0 | 0 | 30,969,000 | 29,190,000 | 26,485,000 | 26,877,000 | 27,266,000 | 44,637,000 | 40,995,000 | 41,256,000 | 39,403,000 | 39,233,000 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cost Of Sales | 0 | 0 | 13,907,000 | 13,986,000 | 13,740,000 | 15,466,000 | 15,870,000 | 24,034,000 | 21,360,000 | 22,388,000 | 21,813,000 | 21,654,000 | |
| Gross Profit | 0 | 0 | 17,062,000 | 15,204,000 | 12,745,000 | 11,411,000 | 11,396,000 | 20,603,000 | 19,635,000 | 18,868,000 | 17,590,000 | 17,579,000 | |
| Admin Expenses | 0 | -819,000 | 13,688,000 | 11,966,000 | 12,691,000 | 10,860,000 | 16,074,000 | 17,700,000 | 13,846,000 | 14,353,000 | 11,934,000 | ||
| Operating Profit | 0 | 819,000 | -1,602,000 | 3,374,000 | 3,238,000 | 54,000 | 551,000 | -4,678,000 | 2,903,000 | 5,022,000 | 3,237,000 | 5,645,000 | |
| Interest Payable | 0 | 0 | 0 | 7,000 | 8,000 | 110,000 | 69,000 | 131,000 | 124,000 | 247,000 | 76,000 | 139,000 | 102,000 |
| Interest Receivable | 9,000 | 29,000 | 63,000 | 0 | 0 | 0 | 150,000 | 0 | 0 | 0 | 0 | 33,000 | 0 |
| Pre-Tax Profit | 12,890,000 | 848,000 | -1,539,000 | 3,447,000 | 3,283,000 | 76,000 | 632,000 | -4,809,000 | 3,081,000 | 3,953,000 | 5,001,000 | 3,261,000 | 5,856,000 |
| Tax | -48,000 | 359,000 | 71,000 | -650,000 | -591,000 | 321,000 | 5,000 | 1,029,000 | -30,000 | 41,000 | -1,136,000 | -854,000 | -1,553,000 |
| Profit After Tax | 12,842,000 | 1,207,000 | -1,468,000 | 2,797,000 | 2,692,000 | 397,000 | 637,000 | -3,780,000 | 3,051,000 | 3,994,000 | 3,865,000 | 2,407,000 | 4,303,000 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 1,406,000 | 1,404,000 | 1,282,000 | 1,182,000 | 1,094,000 | 1,010,000 | 0 |
| Retained Profit | 12,842,000 | 1,207,000 | -1,468,000 | 2,797,000 | 2,692,000 | 397,000 | 33,732,000 | -5,184,000 | 1,769,000 | 2,812,000 | 2,771,000 | 1,397,000 | 4,303,000 |
| Employee Costs | 0 | 0 | 177,000 | 11,578,000 | 10,823,000 | 10,169,000 | 10,563,000 | 11,463,000 | 19,988,000 | 19,265,000 | 17,048,000 | 16,776,000 | 15,021,000 |
| Number Of Employees | 2 | 228 | 220 | 213 | 232 | 257 | 449 | 431 | 406 | 387 | 366 | ||
| EBITDA* | 0 | 819,000 | -1,562,000 | 5,859,000 | 5,480,000 | 2,462,000 | 3,142,000 | -1,189,000 | 7,159,000 | 8,476,000 | 6,484,000 | 8,208,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Nov 2021 | Nov 2020 | Nov 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 502,000 | 546,000 | 590,000 | 6,271,000 | 4,332,000 | 4,662,000 | 5,524,000 | 14,432,000 | 14,963,000 | 13,992,000 | 13,615,000 | 12,281,000 | 11,764,000 |
| Intangible Assets | 0 | 0 | 0 | 5,995,000 | 6,817,000 | 7,568,000 | 8,785,000 | 9,714,000 | 14,009,000 | 12,597,000 | 9,839,000 | 8,705,000 | 8,151,000 |
| Investments & Other | 3,586,000 | 3,586,000 | 3,586,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 1,294,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 4,088,000 | 4,132,000 | 5,470,000 | 12,266,000 | 11,149,000 | 12,230,000 | 14,309,000 | 24,146,000 | 28,972,000 | 26,589,000 | 23,454,000 | 20,986,000 | 19,915,000 |
| Stock & work in progress | 0 | 0 | 0 | 3,272,000 | 3,204,000 | 2,773,000 | 3,547,000 | 3,358,000 | 2,512,000 | 2,752,000 | 1,283,000 | 1,309,000 | 1,157,000 |
| Trade Debtors | 0 | 0 | 0 | 5,771,000 | 5,051,000 | 6,001,000 | 4,633,000 | 9,681,000 | 7,666,000 | 7,784,000 | 8,301,000 | 7,308,000 | 6,717,000 |
| Group Debtors | 3,052,000 | 4,862,000 | 14,792,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 2,000 | 32,000 | 159,000 | 928,000 | 771,000 | 846,000 | 796,000 | 2,109,000 | 2,166,000 | 2,273,000 | 1,148,000 | 706,000 | 867,000 |
| Cash | 13,268,000 | 12,078,000 | 0 | 16,300,000 | 14,586,000 | 8,756,000 | 47,573,000 | 2,840,000 | 3,550,000 | 3,010,000 | 5,179,000 | 6,130,000 | 5,941,000 |
| misc current assets | 0 | 0 | 0 | 1,000 | 88,000 | 44,000 | 0 | 0 | 293,000 | 235,000 | 180,000 | 130,000 | 0 |
| total current assets | 16,322,000 | 16,972,000 | 14,951,000 | 26,272,000 | 23,700,000 | 18,420,000 | 56,549,000 | 17,988,000 | 16,187,000 | 16,054,000 | 16,091,000 | 15,583,000 | 14,682,000 |
| total assets | 20,410,000 | 21,104,000 | 20,421,000 | 38,538,000 | 34,849,000 | 30,650,000 | 70,858,000 | 42,134,000 | 45,159,000 | 42,643,000 | 39,545,000 | 36,569,000 | 34,597,000 |
| Bank overdraft | 0 | 1,000 | 165,000 | 0 | 0 | 0 | 0 | 226,000 | 0 | 0 | 105,000 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 105,000 | 0 | 105,000 | 105,000 |
| Trade Creditors | 0 | 0 | 0 | 1,078,000 | 1,414,000 | 1,235,000 | 1,774,000 | 1,921,000 | 3,400,000 | 3,552,000 | 3,298,000 | 3,337,000 | 3,081,000 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 68,000 | 0 | 224,000 | 9,000 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 104,000 | 0 | 0 | 0 | 28,000 | 132,000 |
| other current liabilities | 53,000 | 47,000 | 407,000 | 5,613,000 | 5,486,000 | 4,691,000 | 2,744,000 | 5,396,000 | 4,122,000 | 4,304,000 | 4,606,000 | 4,507,000 | 6,844,000 |
| total current liabilities | 53,000 | 48,000 | 572,000 | 6,691,000 | 6,900,000 | 5,926,000 | 4,586,000 | 7,647,000 | 7,746,000 | 7,970,000 | 8,009,000 | 7,977,000 | 10,162,000 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,866,000 | 0 | 1,936,000 | 0 | 2,654,000 | 2,794,000 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 348,000 | 0 | 0 | 0 | 0 | 41,000 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 49,000 | 0 | 0 | 0 | 1,309,000 | 0 | 3,937,000 | 0 | 0 |
| provisions | 0 | 0 | 0 | 2,240,000 | 2,280,000 | 1,780,000 | 2,708,000 | 3,994,000 | 5,690,000 | 5,950,000 | 0 | 5,304,000 | 0 |
| total long term liabilities | 0 | 0 | 0 | 1,120,000 | 1,189,000 | 890,000 | 1,354,000 | 3,430,000 | 4,154,000 | 3,943,000 | 3,937,000 | 3,979,000 | 1,472,000 |
| total liabilities | 53,000 | 48,000 | 572,000 | 7,811,000 | 8,089,000 | 6,816,000 | 5,940,000 | 11,077,000 | 11,900,000 | 11,913,000 | 11,946,000 | 11,956,000 | 11,634,000 |
| net assets | 20,357,000 | 21,056,000 | 19,849,000 | 30,727,000 | 26,760,000 | 23,834,000 | 64,918,000 | 31,057,000 | 33,259,000 | 30,730,000 | 27,599,000 | 24,613,000 | 22,963,000 |
| total shareholders funds | 20,357,000 | 21,056,000 | 19,849,000 | 30,727,000 | 26,760,000 | 23,834,000 | 64,918,000 | 31,057,000 | 33,259,000 | 30,730,000 | 27,599,000 | 24,613,000 | 22,963,000 |
| Nov 2021 | Nov 2020 | Nov 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||
| Operating Profit | 0 | 819,000 | -1,602,000 | 3,374,000 | 3,238,000 | 54,000 | 551,000 | -4,678,000 | 2,903,000 | 5,022,000 | 3,237,000 | 5,645,000 | |
| Depreciation | 0 | 0 | 40,000 | 1,308,000 | 1,393,000 | 1,544,000 | 1,616,000 | 1,619,000 | 2,906,000 | 2,664,000 | 2,542,000 | 2,380,000 | 1,744,000 |
| Amortisation | 0 | 0 | 0 | 1,177,000 | 849,000 | 864,000 | 975,000 | 1,870,000 | 1,350,000 | 1,125,000 | 912,000 | 867,000 | 819,000 |
| Tax | -48,000 | 359,000 | 71,000 | -650,000 | -591,000 | 321,000 | 5,000 | 1,029,000 | -30,000 | 41,000 | -1,136,000 | -854,000 | -1,553,000 |
| Stock | 0 | 0 | -3,272,000 | 68,000 | 431,000 | -774,000 | 189,000 | 846,000 | -240,000 | 1,469,000 | -26,000 | 152,000 | 1,157,000 |
| Debtors | -1,840,000 | -11,351,000 | 9,546,000 | 877,000 | -1,025,000 | 1,418,000 | -6,361,000 | 1,958,000 | -225,000 | 608,000 | 1,435,000 | 430,000 | 7,584,000 |
| Creditors | 0 | 0 | -1,078,000 | -336,000 | 179,000 | -539,000 | -147,000 | -1,479,000 | -152,000 | 254,000 | -39,000 | 256,000 | 3,081,000 |
| Accruals and Deferred Income | 6,000 | -360,000 | -5,206,000 | 127,000 | 795,000 | 1,947,000 | -2,652,000 | 1,274,000 | -182,000 | -302,000 | 99,000 | -2,337,000 | 6,844,000 |
| Deferred Taxes & Provisions | 0 | 0 | -2,240,000 | -40,000 | 500,000 | -928,000 | -1,286,000 | -1,696,000 | -260,000 | 5,950,000 | -5,304,000 | 5,304,000 | 0 |
| Cash flow from operations | 1,798,000 | 12,169,000 | -16,289,000 | 4,015,000 | 6,957,000 | 2,619,000 | 5,234,000 | -4,865,000 | 7,000,000 | 687,000 | 8,271,000 | 7,839,000 | |
| Investing Activities | |||||||||||||
| capital expenditure | |||||||||||||
| Change in Investments | 0 | 0 | 3,586,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||||||||
| Financing Activities | |||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -105,000 | 105,000 | -105,000 | 0 | 105,000 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | -68,000 | 68,000 | -224,000 | 215,000 | 9,000 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | -2,866,000 | 2,866,000 | -1,936,000 | 1,936,000 | -2,654,000 | -140,000 | 2,794,000 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | -452,000 | 452,000 | 0 | 0 | -28,000 | -145,000 | 173,000 |
| other long term liabilities | 0 | 0 | 0 | -49,000 | 49,000 | 0 | 0 | -1,309,000 | 1,309,000 | -3,937,000 | 3,937,000 | 0 | 0 |
| share issue | |||||||||||||
| interest | 9,000 | 29,000 | 63,000 | -7,000 | -8,000 | -110,000 | 81,000 | -131,000 | -124,000 | -247,000 | -76,000 | -106,000 | -102,000 |
| cash flow from financing | -13,532,000 | 29,000 | -9,347,000 | 1,114,000 | 275,000 | -41,659,000 | -3,040,000 | 4,636,000 | 119,000 | -1,815,000 | 1,289,000 | -138,000 | 21,630,000 |
| cash and cash equivalents | |||||||||||||
| cash | 1,190,000 | 12,078,000 | -16,300,000 | 1,714,000 | 5,830,000 | -38,817,000 | 44,733,000 | -710,000 | 540,000 | -2,169,000 | -951,000 | 189,000 | 5,941,000 |
| overdraft | -1,000 | -164,000 | 165,000 | 0 | 0 | 0 | -226,000 | 226,000 | 0 | -105,000 | 105,000 | 0 | 0 |
| change in cash | 1,191,000 | 12,242,000 | -16,465,000 | 1,714,000 | 5,830,000 | -38,817,000 | 44,959,000 | -936,000 | 540,000 | -2,064,000 | -1,056,000 | 189,000 | 5,941,000 |
bioquell limited Credit Report and Business Information
Bioquell Limited Competitor Analysis
Perform a competitor analysis for bioquell limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
bioquell limited Ownership
BIOQUELL LIMITED group structure
Bioquell Limited has 1 subsidiary company.
Ultimate parent company
ECOLAB INC
#0053954
2 parents
BIOQUELL LIMITED
00206372
1 subsidiary
bioquell limited directors
Bioquell Limited currently has 5 directors. The longest serving directors include Mr Nihad Hasagic (May 2019) and Mr Eric De Villemeur (Jul 2020).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Nihad Hasagic | 55 years | May 2019 | - | Director | |
| Mr Eric De Villemeur | 39 years | Jul 2020 | - | Director | |
| Mr Paul Hey | England | 59 years | Jul 2020 | - | Director |
| Mrs Debra Hough | United Kingdom | 49 years | Jan 2022 | - | Director |
| Miss Claire Thompson | United Kingdom | 44 years | Nov 2022 | - | Director |
P&L
November 2021turnover
0
0%
operating profit
0
-100%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
November 2021net assets
20.4m
-0.03%
total assets
20.4m
-0.03%
cash
13.3m
+0.1%
net assets
Total assets minus all liabilities
Similar Companies
bioquell limited company details
company number
00206372
Type
Private limited with Share Capital
industry
64209 - Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
incorporation date
June 1925
age
99
accounts
Full Accounts
ultimate parent company
previous names
bioquell plc (October 2019)
kynoch group plc (May 2000)
incorporated
UK
address
c/o hill dickinson, no.1 st. paul's square, liverpool, england, L3 9SJ
last accounts submitted
November 2021
bioquell limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 9 charges/mortgages relating to bioquell limited. Currently there are 0 open charges and 9 have been satisfied in the past.
bioquell limited Companies House Filings - See Documents
| date | description | view/download |
|---|
